Home
Storia in 1 fonti
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.
Raccontata da
cnbc.com
- ·
How the UK fell out with big pharma
The U.K. is in the midst of a falling out with big pharma over drug pricing. Merck has walked away from a £1 billion facility in London and pulled its research activities…
- ·
UK has gone from a leader to a laggard in biopharma, Eli Lilly CEO says
Eli Lilly Chief Executive Officer Dave Ricks says a pullback in U.K. biopharmaceutical investments should send a message to U.S. policymakers.